Further genome-wide transcriptome analysis identified that BRD4 and Snail modulated partially shared metastatic gene signature. Otto et al. [32] found that inhibition and degradation of BRD4 are powerful tools for reducing MYC expression and CRC cell proliferation. The gene discussed is MYC; the disease is colorectal carcinoma.